Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?

Murine Recombinant Angiotensin-Converting Enzyme 2

(2012) Minghao Ye et al.   HYPERTENSION

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

(2012) Renisha Nadarajah et al.   KIDNEY INTERNATIONAL

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications

(2011) Aino Soro-Paavonen et al.   JOURNAL OF HYPERTENSION

Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy

(2011) Daniel Batlle et al.   KIDNEY INTERNATIONAL

Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study

(2011) Alberto Martínez-Castelao et al.   BMC Nephrology

Vascular Angiotensin-Converting Enzyme 2

(2010) Daniel Batlle et al.   CIRCULATION RESEARCH

Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases

(2010) Yuko Takahashi et al.   ARTHRITIS RESEARCH & THERAPY

New aspects of the renin–angiotensin system: angiotensin-converting enzyme 2 – a potential target for treatment of hypertension and diabetic nephropathy

(2009) Daniel Batlle et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2

(2009) Jan Wysocki et al.   HYPERTENSION

ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes

(2008) C. Tikellis et al.   DIABETES

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor

(2008) Rebecca A. Lew et al.   EXPERIMENTAL PHYSIOLOGY

Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure

(2008) Slava Epelman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY